Logo image
Effect of inhaled albuterol on whole blood potassium concentrations in dogs
Journal article   Open access   Peer reviewed

Effect of inhaled albuterol on whole blood potassium concentrations in dogs

Andrezej Ogrodny, Jared A. Jaffey, Rachael Kreisler, Mark Acierno, Teela Jones, Renata S. Costa, Anderson da Cunha and Emily Westerback
Journal of veterinary internal medicine, Vol.36(6), pp.2002-2008
2022
PMID: 36178135
pdf
Published816.60 kBDownloadView
CC BY-NC-ND V4.0 Open Access

Abstract

Life Sciences & Biomedicine Science & Technology Veterinary Sciences
Background: Albuterol by inhalation (IH) is a common treatment for hyperkalemia in humans but its effect on blood potassium concentrations in dogs is unknown. Objective: Determine whether albuterol (IH) decreases blood potassium concentrations in healthy normokalemic dogs and if effects are dose-dependent. Animals: Ten healthy dogs. Methods: Prospective, crossover experimental study. Albuterol sulfate was administered at a low-dose (90 mu g) in phase I and, 7 days later, high-dose (450 mu g) in phase II. Blood potassium and glucose concentrations (measured via blood gas analyzer) and heart rates were obtained at baseline and then 3, 5, 10, 15, 30, 60, 90, 120, 180, and 360 minutes after inhaler actuation. Results: Blood potassium concentrations decreased rapidly after albuterol delivery with a significant reduction compared to baseline within 30 minutes in both phases (P = .05). The potassium nadir concentration of phase I occurred at 60 minutes (mean, SD; 4.07 mmol/L, 0.4) and was significantly decreased from baseline, (4.30 mmol/L, 0.3; t(9) = 2.40, P = .04). The potassium nadir concentration of phase II occurred at 30 minutes (mean, SD; 3.96 mmol/L, 0.39) and was also significantly decreased from baseline, (4.33 mmol/L, 0.4; t(9) = 2.22, P = .05). The potassium nadir concentration decreased by 0.1 mmol/L for each 10 mu g/kg increase in dose of albuterol (P = .01). Five dogs had >= 1 hyperglycemic measurement (ie, >112 mg/dL). No median heart rate was tachycardic nor was any mean blood glucose concentration hyperglycemic at any time point. Conclusion and Clinical Importance: Albuterol IH decreases blood potassium concentrations in a dose-dependent manner without clinically meaningful alterations to heart rate or blood glucose concentrations in healthy dogs. The mean decrease in potassium concentration at the high-dose of albuterol was modest (0.38 mmol/L).

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

3 File views/ downloads
74 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.55 Urology & Nephrology - General
1.55.2271 Hyperkalemia
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image